The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents. The ONCOFID-P® paradigm

Pharmacological Research

Volumn 58, Issue 5-6, 2008, Pages 340-343

  Tringali, Giuseppe ^a   Lisi, Lucia ^a   Bettella, Fabio ^b   Renier, Davide ^b   Di Stasi, Savino M ^c   Navarra, Pierluigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Fidia Advanced Biopolymers   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Bladder; Hyaluronic acid; Intravesical route; Paclitaxel; rabbit; Transport; Urothelium

Indexed keywords

ANTINEOPLASTIC AGENT; ONCOFID P; PACLITAXEL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLADDER; BLADDER MUCOSA; CONTROLLED STUDY; DRUG ABSORPTION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MALE; MODEL; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYALURONIC ACID; INDICATORS AND REAGENTS; MALE; PACLITAXEL; RABBITS; SPECTROPHOTOMETRY, ULTRAVIOLET; URINARY BLADDER; UROTHELIUM;

EID: 56649124637     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.09.008     Document Type: Article

References (26)

1. Hall M.C., Chang S.S., Dalbagni G., Pruthi R.S., Seigne J.D., Skinner E.C., et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178 6 (2007) 2314-2330
2. Witjes J.A., and Hendricksen K. Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol 53 (2008) 45-52
3. Di Stasi S.M., Giannantoni A., Stephen R.L., Capelli G., Navarra P., Massoud R., et al. Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. J Urol 170 (2003) 777-782
4. Di Stasi S.M., Giannantoni A., Massoud R., Dolci S., Navarra P., Vespasiani G., et al. Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies. Cancer Res 59 (1999) 4912-4918
5. Di Stasi S.M., Vespasiani G., Giannantoni A., Massoud R., Dolci S., and Micali F. Electromotive delivery of mitomycin C into human bladder wall. Cancer Res 57 (1997) 875-880
6. Kato K., Kitada S., Chun A., Wein A.J., and Levin R.M. In vitro intravesical instillation of anticholinergic, antispasmodic and calcium blocking agents (rabbit whole bladder model). J Urol 141 (1989) 1471-1475
7. Matsumoto S., Chichester P., Bratslavsky G., Kogan B.A., and Levin R.M. The functional and structural response to distension of the rabbit whole bladder in vitro. J Urol 168 (2002) 2677-2681
8. Tammela T., Wein A.J., Monson F.C., and Levin R.M. Urothelial permeability of the isolated whole bladder. Neurourol Urodyn 12 (1993) 39-47
9. Agartan C.A., Whitbeck C., Chichester P., Kogan B.A., and Levin R.M. Effect of age on rabbit bladder function and structure following partial outlet obstruction. J Urol 173 (2005) 1400-1405
10. Landau E.H., Fung L.C., Thorner P.S., Mittelman M.W., Jayanthi V.R., Churchill B.M., et al. Histologic studies of intravesical oxybutynin in the rabbit. J Urol 153 (1995) 2022-2024
11. Rosato A., Banzato A., De Luca G., Renier D., Bettella F., Pagano C., et al. HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer. Urol Oncol 24 (2006) 207-215
12. Song D., Wientjes M.G., and Au J.L. Bladder tissue pharmacokinetics of intravesical taxol. Cancer Chemother Pharmacol 40 (1997) 285-292
13. Rangel C., Niell H., Miller A., and Cox C. Taxol and taxotere in bladder cancer: in vitro activity and urine stability. Cancer Chemother Pharmacol 33 (1994) 460-464
14. Au J.L., Kalns J., Gan Y., and Wientjes M.G. Pharmacologic effects of paclitaxel in human bladder tumors. Cancer Chemother Pharmacol 41 (1997) 69-74
15. Nativ O., Aronson M., Medalia O., Moldavsky T., Sabo E., Ringel I., et al. Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer: in vivo and in vitro studies. Int J Cancer 70 (1997) 297-301
16. Knemeyer I., Wientjes M.G., and Au J.L. Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment. Cancer Chemother Pharmacol 44 (1999) 241-248
17. Chen D., Song D., Wientjes M.G., and Au J.L. Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel. Clin Cancer Res 9 (2003) 363-369
18. Le Visage C., Rioux-Leclercq N., Haller M., Breton P., Malavaud B., and Leong K. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer. J Urol 171 (2004) 1324-1329
19. Lu Z., Yeh T.K., Tsai M., Au J.L., and Wientjes M.G. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res 10 (2004) 7677-7684
20. Lee S.J., Kim S.W., Chung H., Park Y.T., Choi Y.W., Cho Y.H., et al. Bioadhesive drug delivery system using glyceryl monooleate for the intravesical administration of paclitaxel. Chemotherapy 51 (2005) 311-318
21. Southgate J., Trejdosiewicz L.K., Smith B., and Selby P.J. Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines. Int J Cancer 62 (1995) 449-456
22. Arafat H.A., Wein A.J., and Chacko S. Osteopontin gene expression and immunolocalization in the rabbit urinary tract. J Urol 167 (2002) 746-752
23. Naor D., Sionov R.V., and Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res 71 (1997) 241-319
24. Galluzzo E., Albi N., Fiorucci S., Merigiola C., Ruggeri L., Tosti A., et al. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol 25 (1995) 2932-2939
25. Wientjes M.G., Badalament R.A., Wang R.C., Hassan F., and Au J.L. Penetration of mitomycin C in human bladder. Cancer Res 53 (1993) 3314-3320
26. Wientjes M.G., Dalton J.T., Badalament R.A., Drago J.R., and Au J.L. Bladder wall penetration of intravesical mitomycin C in dogs. Cancer Res 51 (1991) 4347-4354